Fjorten procent af patienterne havde ikke tidligere fået kemoterapi; 27% havde alene fået kemoterapi som adjuverende behandling, 40% alene som behandling for metastaserende sygdom og 19% havde fået både adjuverende behandling og behandling for metastaserende sygdom.
Fourteen percent of the patients had not received prior chemotherapy; 27% had received chemotherapy in the adjuvant setting only, 40% in the metastatic setting only, and 19% in both metastatic and adjuvant settings.